Meeting
2017 ASCO Annual Meeting
Safety of multiplex gene testing for inherited cancer risk in a fully accrued prospective trial.
Authors
Allison W. Kurian
Stanford School of Medicine, Stanford, CA
Allison W. Kurian , Gregory Idos , Charite Nicolette Ricker , Julie Culver , Duveen Sturgeon , Kerry Kingham , Rachel Koff , Katrina Lowstuter , Nicolette M. Chun , Courtney Rowe-Teeter , Katlyn Partynski , Anne-Renee Hartman , Brian Allen , John Kidd , Meredith Mills , Christine Hong , Kevin McDonnell , Uri Ladabaum , James M. Ford , Stephen B. Gruber
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention, Genetics, and Epidemiology
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Clinical Trial Registration Number
NCT02324062
Citation
J Clin Oncol 35, 2017 (suppl; abstr 1576)
DOI
10.1200/JCO.2017.35.15_suppl.1576
Abstract #
1576
Poster Bd #
234
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Expanded yield of multiplex panel testing in fully accrued prospective trial.
First Author: Gregory Idos
Poster
2017 ASCO Annual Meeting
Performance of mutation risk prediction models in a racially diverse multi-gene panel testing cohort.
First Author: Gregory Idos
Poster
2019 ASCO Annual Meeting
Prevalence and penetrance of breast cancer-associated mutations identified by multiple-gene sequencing in the Women’s Health Initiative.
First Author: Allison W. Kurian
Poster
2016 ASCO Annual Meeting
Prospective registry of multiplex testing (PROMPT): A web-based platform to assess cancer risk of genetic variants.
First Author: Michael Francis Walsh